Who’s taking Ozempic? New data reveals ‘significant’ shift, prompts shortage fears - New York Post
- Who’s taking Ozempic? New data reveals ‘significant’ shift, prompts shortage fears New York Post
- GLP-1s Are Growing In Popularity As Weight Loss Drugs But Losing Steam Among Diabetics, Study Suggests Forbes
- Most people taking GLP-1s like Ozempic are white women — plus 4 other takeaways from a new study Yahoo Life
- As GLP-1 Demand Goes Up, Access and Coverage Go Down Medscape